9-134817127-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000093.5(COL5A1):c.4176+48A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.419 in 1,550,680 control chromosomes in the GnomAD database, including 138,602 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.47 ( 17322 hom., cov: 33)
Exomes 𝑓: 0.41 ( 121280 hom. )
Consequence
COL5A1
NM_000093.5 intron
NM_000093.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.27
Publications
7 publications found
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- Ehlers-Danlos syndrome, classic type, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- arterial disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 9-134817127-A-G is Benign according to our data. Variant chr9-134817127-A-G is described in ClinVar as [Benign]. Clinvar id is 255086.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.616 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL5A1 | NM_000093.5 | c.4176+48A>G | intron_variant | Intron 53 of 65 | ENST00000371817.8 | NP_000084.3 | ||
COL5A1 | NM_001278074.1 | c.4176+48A>G | intron_variant | Intron 53 of 65 | NP_001265003.1 | |||
COL5A1 | XM_017014266.3 | c.4176+48A>G | intron_variant | Intron 53 of 64 | XP_016869755.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.467 AC: 70824AN: 151782Hom.: 17296 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
70824
AN:
151782
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.416 AC: 102242AN: 246056 AF XY: 0.409 show subpopulations
GnomAD2 exomes
AF:
AC:
102242
AN:
246056
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.414 AC: 578778AN: 1398780Hom.: 121280 Cov.: 24 AF XY: 0.412 AC XY: 288278AN XY: 699394 show subpopulations
GnomAD4 exome
AF:
AC:
578778
AN:
1398780
Hom.:
Cov.:
24
AF XY:
AC XY:
288278
AN XY:
699394
show subpopulations
African (AFR)
AF:
AC:
20540
AN:
32512
American (AMR)
AF:
AC:
16581
AN:
44196
Ashkenazi Jewish (ASJ)
AF:
AC:
9463
AN:
25656
East Asian (EAS)
AF:
AC:
17761
AN:
39340
South Asian (SAS)
AF:
AC:
29905
AN:
84924
European-Finnish (FIN)
AF:
AC:
19048
AN:
52872
Middle Eastern (MID)
AF:
AC:
2276
AN:
5164
European-Non Finnish (NFE)
AF:
AC:
438733
AN:
1055830
Other (OTH)
AF:
AC:
24471
AN:
58286
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
14192
28384
42576
56768
70960
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.467 AC: 70902AN: 151900Hom.: 17322 Cov.: 33 AF XY: 0.460 AC XY: 34126AN XY: 74260 show subpopulations
GnomAD4 genome
AF:
AC:
70902
AN:
151900
Hom.:
Cov.:
33
AF XY:
AC XY:
34126
AN XY:
74260
show subpopulations
African (AFR)
AF:
AC:
25780
AN:
41414
American (AMR)
AF:
AC:
6017
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
1265
AN:
3464
East Asian (EAS)
AF:
AC:
2364
AN:
5150
South Asian (SAS)
AF:
AC:
1625
AN:
4804
European-Finnish (FIN)
AF:
AC:
3848
AN:
10568
Middle Eastern (MID)
AF:
AC:
134
AN:
294
European-Non Finnish (NFE)
AF:
AC:
28559
AN:
67908
Other (OTH)
AF:
AC:
952
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1929
3858
5787
7716
9645
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1399
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Fibromuscular dysplasia, multifocal Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Ehlers-Danlos syndrome, classic type, 1 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.